SUMMARY A retrospective study was carried out to assess the incidence of cardiomyopathy in western Denmark (Jutland and Funen) (population 2 798 000) during a two year period . The WHO/ISCF classification was strictly followed, and rigid criteria for exclusion and inclusion of patients were adopted. Thus cases in which specific heart muscle disorders (myocarditis, alcoholic heart disease, hypertension etc) were merely suspected were excluded. Forty one patients had dilated cardiomyopathy (overall incidence 7-3/106 population/year) and 20 hypertrophic cardiomyopathy (overall incidence 3.6/106 population/year). In men aged 40-59 years the occurrence of dilated cardiomyopathy was 23.4/106 population/year. Only one case of Loffler's endomyocardial disease was diagnosed during the study period. Since the investigation was retrospective and was a study of diseased persons and not a population, and since a specific set of criteria for exclusion and inclusion was rigidly applied, the results represent the minimum frequency of these diseases.
When reviewing cardiomyopathies more than 10 years ago Oakley emphasised that there was "an apparent contentment with the diagnosis of coronary heart disease in our western society."' This attitude has changed, as evidenced by the vast number of published reports on cardiomyopathy and lately on myocarditis. Nevertheless, the fundamental question of the occurrence of cardiomyopathy as defined by the WHO/ISCF Task Force Group2 is still largely unknown; only Torp's study3 from the Malmo area in southern Sweden offers an answer to that question.
We carried out a retrospective study in western Denmark (Jutland and Funen) to establish the frequency of cardiomyopathy in that region.
Patients and methods
The clinical notes or necropsy reports or both were retrospectively studied for all patients in western Denmark (Jutland and Funen, population 2 798 000) who had a first time diagnosis of cardiomyopathy (ICD code number 425) during the period 1 January
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Accepted for publication 12 June 1984 1980 to 31 December 1981. All the survivors were investigated at one of the three cardiac departments serving this demographically well defined area.
Information on the necropsy results was obtained from the 12 departments of pathology and the two institutes of forensic medicine in the area. EXCLUSION 
CRITERIA

Following the recommendations of the Task Force
Group on cardiomyopathy2 we adopted strict criteria for the exclusion and inclusion of patients. Those A family history of heart disease other than of ischaemic or valvar origin was present in 28% of patients (proved in 15%) with dilated cardiomyopathy and in 54% of patients (proved in 31%) with hypertrophic cardiomyopathy.
SEX AND AGE DISTRIBUTION
The age of patients with dilated cardiomyopathy ranged from 8-79 years and with hypertrophic cardiomyopathy from 19-84 years. Table 1 shows the sex and age distribution. Almost twice as many male as female patients had dilated cardiomyopathy, whereas the sex distribution was equal in those with hypertrophic cardiomyopathy. More than half of the male patients with dilated cardiomyopathy (n= 14) were between 40-59 years old (population 299 000), which gives a frequency of 23-4/106 population/year for dilated cardiomyopathy in this group.
DIAGNOSIS
A diagnosis of cardiomyopathy was initially based on cardiac catheterisation or echocardiographic investigation (Table 2 ). An 8 year old girl had dilatation of the Died (total number) 21 6
group.bmj.com on October 22, 2017 -Published by http://heart.bmj.com/ Downloaded from Cardiomyopathy in western Denmark right ventricle only (right ventricular internal diameter in diastole 24 mm); the pressures in the right ventricle were normal and there were no arteriovenous shunts. An intraventricular pressure gradient (mean 68 (range 20-112) mm Hg) was found in 10 of 14 patients with hypertrophic cardiomyopathy in whom catheterisation was performed.
Coronary arteriography showed no abnormalities in 14 patients with dilated cardiomyopathy and in six with hypertrophic cardiomyopathy. In addition, necropsy showed normal coronary arteries in 17 patients with dilaied cardiomyopathy and in five patients with hypertrophic cardiomyopathy. Thus normal coronary anatomy was found in 31 (76%) patients with dilated cardiomyopathy and in 11 (55%) with hypertrophic cardiomyopathy.
Necropsy alone established the diagnosis of dilated cardiomyopathy in 11 patients. Of these, seven had experienced symptoms (especially dyspnoea) for 1-9 years and were among the eldest patients (mean age 66 (range 41-79) years), whereas four died suddenly with no known symptoms of heart disease. During the study period and the following six months 10 patients with dilated cardiomyopathy died (mean age 45 (range 24-65) years). In eight of these necropsy was performed. The diagnosis of dilated cardiomyopathy was thus confirmed at necropsy in 19 (46%) patients.
In the group with hypertrophic cardiomyopathy surgical biopsy during myomectomy (three patients) or necropsy specimens (six patients) confirmed the diagnosis in nine (45%) patients. Two of the six patients in whom necropsy was performed had no known symptoms of heart disease. Altogether four patients with hypertrophic cardiomyopathy died suddenly.
SYMPTOMS
Patients with dilated cardiomyopathy had one or more symptoms for a mean period of three years (range 0-17 years) before the diagnosis was established, whereas those with hypertrophic cardiomyopathy had had symptom(s) for a mean of five years (range 0-22 years).
Dyspnoea was the most prevalent finding in both groups, although heart failure was almost exclusively found in patients with dilated cardiomyopathy (Table 3) . One patient with dilated cardiomyopathy had systemic embolism. A systolic murmur was found in nearly all patients with hypertrophic cardiomyopathy compared with less than half of those with dilated cardiomyopathy (Table 3) .
ELECTROCARDIOGRAPHIC AND RADIOLOGICAL DATA AND BLOOD PRESSURE Table 4 shows the radiological and electrocardiographic data. An increased cardiothoracic ratio was 329 
Discussion
During the two year period of the study the diagnosis of cardiomyopathy based on catheterisation or echocardiography or both could be established only at the three cardiac departments serving the region of western Denmark. We assumed that all patients with suspected cardiomyopathy were referred to one of these three departments, an assumption for which we have verbal confirmation. The necropsy data were collected from the 12 departments of pathology and two institutes of forensic medicine in the area, and all available specimens for histological examination were studied by the same pathologist.
Our criteria for inclusion and exclusion may not be universally acceptable. A review of the literature shows, however, that specific and detailed criteria are difficult to find or are non-existent. It was therefore necessary to formulate such criteria, which we consider are sufficiently precise for future comparison.
There are several reasons why our figures may appear low; they are certainly minimum figures. Firstly, we did not investigate a population but only assessed the available information in patients in whom cardiomyopathy was already diagnosed. Thus we are faced with all the problems of a retrospective survey: how often was a correct diagnosis of cardiomyopathy missed? were all the patients with cardiomyopathy referred?
Secondly, and most importantly, we made oui criteria so rigid that a suspicion of any specific heart muscle disorder (for example) resulted in exclusion from the study. Dilated cardiomyopathy is thought to be a condition of multifactorial origin. 14 In particular, (viral) myocarditis may be the cause of a proportion of cases probably by way of an immunological pathogenesis.'I The problem is, however, that there is a large grey zone of overlapping conditions: chronic myocarditis, healed myocarditis, sequelae of myocarditis, and dilated cardiomyopathy. It should be emphasised that our approach was to exclude patients in whom a diagnosis of present or past myocarditis was suspected. We made every possible effort to exclude coronary heart disease, which may mimic cardiomyopathy clinically (especially dilated cardiomyopathy).
The incidence of cardiomyopathy varies in different parts of the world; not only varying diagnostic criteria but also geographical differences affect the figures. Loffler's endomyocardial disease is certainly much Bagger, Baandrup, Rasmussen, Moller, Vesterlund more frequent in Africa than in Europe.'6 To our knowledge, Torp's study from Sweden3 is the only one of the incidence of dilated cardiomyopathy. Since there are probably no major differences between the population of southern Sweden and western Denmark his data should be comparable with ours. Nevertheless, Torp found the incidence of dilated cardiomyopathy to be seven times higher than we did. How can this be explained?
The study population of 250 000 in Torp's study was served by only one hospital. In our area many general departments of internal medicine were concerned in the study, and, although all three cardiac departments of the region participated in the investigation, some patients may have escaped referral to one of these during the study period. Torp reports a necropsy rate of about 900/o for admitted patients; no figure is given for patients dying outside hospital. In our target area necropsy was performed in 30%/o of all deaths during the study period.'7 Fifty four per cent of deaths occurred in hospital, and of those approximately 500/o were examined at necropsy. These figures certainly point to an underestimation of the incidence.
In Torp's study the only specific criteria for a diagnosis of dilated cardiomyopathy were based on a mean pulmonary artery wedge pressure of > 12 mm Hg at rest and of > 16 mm Hg during submaximal exercise, a heart size > 500 ml/m2, and a cardiac index and stroke volume index <2*8 1/minim2 and <30 ml/ beat/M2 respectively. These criteria would include "early cases" or cases of suspected cardiomyopathy. In the present study, however, we aimed to include only definite cases of cardiomyopathy.
The mortality rate in Torp's study (nine out of 59 patients died over a period of eight years) was lower than that in ours (10 out In our study the number of patients with hypertrophic cardiomyopathy was about half that of those with the dilated type. This figure includes patients with symptomatic disease and those who died without any known heart disease. This result is lower than previously suggested especially if asymptomatic cases are included.3 20 Specific data are, however, not available.
Our investigation indicated that relatives of about 500/o of the patients had hypertrophic cardiomyopathy, although this was proved in only 31% of the patients. These relatives were identified previously because of their symptoms and did not influence our results. Since asymptomatic forms of hypertrophic cardiomyopathy may be detected by echocardiography the incidence of that disorder would undoubtedly be higher if this study had been undertaken as a screening procedure. A family history of dilated cardiomyopathy in 28% of patients with dilated cardiomyopathy and in 54% with hypertrophic cardiomyopathy compares well with the findings of Emanuel et al's study from 1972.2 1 The present data indicate the minimum figures for the occurrence of symptomatic cardiomyopathy confirmed at necropsy obtained by a retrospective survey in western Denmark. A prospective study would undoubtedly show a higher frequency. More precise data would, however, require a population study based on an echocardiographic evaluation with subsequent coronary arteriography and histological examination of biopsy specimens in cases suspected of dilated cardiomyopathy. A study of this design is not possible for practical and ethical reasons, and the many problems of defining early cases would still remain. A definition of disease including the terms unknown/idiopathic is not satisfactory but is unfortunately often realistic. Increased insight and experience in determining the incidence of such disorders will naturally reduce the number of cases; in the study of the cardiomyopathies great progress has been made during the past 20 years. Thus Loffler's endomyocardial disease could probably be omitted from the cardiomyopathy group and be transferred to the group of specific heart muscle disorders when the WHO/ISCF Task Force Group issues niew guidelines. We thank all who referred patients to us and made necropsy material available.
